Earnings Scheduled For May 5, 2022
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
From Pharmacist To Successful Cannabis Exec, Jason Wild Of TerrAscend: Meet Our Keynote Speakers
It is well known that a career is a lifelong journey that can take many turns. Today we’re…
Guggenheim Initiates Coverage On Stem with Buy Rating, Announces Price Target of $16
Guggenheim analyst Joseph Osha initiates coverage on Stem (NYSE:STEM) with a Buy rating and announces Price Target of $16.
Executives Buy Around $22M Of 4 Stocks
Although US stock futures traded lower this morning on Friday, there were a few notable insider trades.
Another Cannabis Delivery App Lands On Apple Store: TerrAscend’s The Apothecarium App Available In New Jersey & California
TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) has launched The Apothecarium mobile retail app for Apple iOS devices.
Cannabis Movers & Shakers: HEXO, Kaya Now, Greenlane, Stem Holdings
Kaya Now Welcomes Stormy Simon As Director Of Board
Kaya Now Inc., a media and technology holding company, focused on the cannabis industry, has appointed Stormy Simon to its board of directors.
Stem Holdings Appoints Two New Members To Its Board of Directors
Stem Holdings, Inc. (OTCQX:STMH) (CSE:STEM), vertically integrated cannabis operator, appointed Daryl Simon and Rajiv Rai to its Board of Directors effective March 4, 2022.
93 Biggest Movers From Friday
Gainers
Inspirato Incorporated (NASDAQ: ISPO) shares surged 50.5% to close at $54.90.
